{
  "docId": "019dd923-622c-750b-8b9b-9646c0061f4f",
  "docSlug": "002774f67694",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-05-04 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 5,
  "pageCount": 47,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "This slide provides a high-level company profile and performance summary.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-9646c0061f4f/5",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Today, PAH trades at $27.40 per share, a ~175% increase from its public offering price just two years ago",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70f3-714d-84c8-21130f64a6bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.85,
        "x": 0.08,
        "y": 0.23
      },
      "kind": "list",
      "text": "Martin Franklin, Chairman of Jarden, and private investor Nicolas Berggruen co-founded PAH in early 2013\nIn May 2013, PAH raised approximately $900mm(1) in a public offering at $10 per share\nIn October 2013, PAH announced the acquisition of MacDermid Inc., a specialty chemical company, for $1.8bn\nPAH has subsequently acquired three businesses in the agricultural chemicals industry for approximately $5 billion\nToday, PAH trades at $27.40 per share, a ~175% increase from its public offering price just two years ago",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "400e3354-98ba-4907-af64-72b8889ba367",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "share price appreciation: ~175%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-70f3-714d-84c8-24bbde02577f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.08,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "(1) http://ir.platformspecialtyproducts.com/faq.cfm",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2d6bcf58-9160-4fbb-a143-345794c0c1bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.08,
        "y": 0.13
      },
      "kind": "title",
      "text": "Platform Specialty Products (NYSE: PAH)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa098773-fb11-4e89-8091-9b099e1c22cc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}